LDHA and melanoma: On the other hand, a recently reported LDH-A inhibitor, ML-05, reduces the ECAR and the relative ATP levels in melanoma cells (B16F10) after treatment [28], indicating its potential for further investigation with LDH-A inhibitors in other types of cancer cells.